Omada Health (NASDAQ:OMDA) CAO Sells $43,743.00 in Stock

Omada Health, Inc. (NASDAQ:OMDA) CAO Craig Gracey sold 2,083 shares of the stock in a transaction dated Monday, June 29th. The shares were sold at an average price of $21.00, for a total transaction of $43,743.00. Following the completion of the transaction, the chief accounting officer directly owned 858 shares in the company, valued at $18,018. The trade was a 70.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Craig Gracey also recently made the following trade(s):

• On Wednesday, July 1st, Craig Gracey sold 637 shares of Omada Health stock. The stock was sold at an average price of $23.00, for a total transaction of $14,651.00.
• On Tuesday, June 30th, Craig Gracey sold 405 shares of Omada Health stock. The shares were sold at an average price of $22.00, for a total transaction of $8,910.00.
• On Friday, June 26th, Craig Gracey sold 2,084 shares of Omada Health stock. The shares were sold at an average price of $20.00, for a total transaction of $41,680.00.
• On Wednesday, June 24th, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $19.01, for a total transaction of $39,597.83.
• On Monday, June 22nd, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $18.00, for a total value of $37,494.00.
• On Friday, June 12th, Craig Gracey sold 6,894 shares of Omada Health stock. The shares were sold at an average price of $17.42, for a total value of $120,093.48.

Omada Health Trading Down 1.0%

Shares of NASDAQ OMDA opened at $22.39 on Friday. The firm has a market cap of $1.33 billion and a P/E ratio of -82.93. The business’s 50 day moving average is $17.16 and its 200-day moving average is $15.03. Omada Health, Inc. has a 1-year low of $10.28 and a 1-year high of $26.92.

Omada Health (NASDAQ:OMDA) last released its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.03. The business had revenue of $78.05 million during the quarter. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%. Analysts forecast that Omada Health, Inc. will post -0.01 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts have issued reports on OMDA shares. Canaccord Genuity Group set a $24.00 price objective on shares of Omada Health in a report on Friday, May 8th. BMO Capital Markets dropped their price target on shares of Omada Health from $27.00 to $18.00 and set an “outperform” rating for the company in a research report on Friday, March 6th. JPMorgan Chase & Co. cut their price target on Omada Health from $32.00 to $26.00 and set an “overweight” rating for the company in a research note on Thursday, March 12th. Evercore reissued an “outperform” rating and set a $20.00 price target on shares of Omada Health in a research report on Friday, May 8th. Finally, Needham & Company LLC restated a “buy” rating and set a $28.00 price objective on shares of Omada Health in a research note on Friday, May 8th. Ten investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $22.91.

Institutional Investors Weigh In On Omada Health

A number of large investors have recently modified their holdings of OMDA. Geode Capital Management LLC bought a new stake in shares of Omada Health during the 2nd quarter worth $637,000. Walleye Capital LLC acquired a new stake in shares of Omada Health in the 2nd quarter valued at approximately $458,000. Ilex Capital Partners UK LLP acquired a new stake in shares of Omada Health in the 2nd quarter valued at approximately $201,000. Soros Fund Management LLC bought a new stake in shares of Omada Health during the 2nd quarter valued at approximately $640,000. Finally, Raymond James Financial Inc. acquired a new position in Omada Health during the 2nd quarter worth approximately $32,000.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.